| Trial ID: | L0516 |
| Source ID: | JPRN-UMIN000030548
|
| Associated Drug: |
Pioglitazone
|
| Title: |
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
type 2 diabetes mellitus, NAFLD, NASH
|
| Interventions: |
Dapagliflozin 5 mg/day, 104 weeks<br>Pioglitazone 15-30 mg/day, 104 weeks
|
| Outcome Measures: |
HbA1c, hepatic attenuation compared with spleen on CT scan imagingnan
|
| Sponsor/Collaborators: |
Saitama Medical University Hospital
|
| Gender: |
All
|
| Age: |
20years-old80years-old
|
| Phases: |
Not applicable
|
| Enrollment: |
100
|
| Study Type: |
Interventional
|
| Study Designs: |
Parallel Randomized
|
| Start Date: |
25/12/2017
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
2 April 2019
|
| Locations: |
Japan
|
| URL: |
https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034855
|
